{
    "id": 27456,
    "fullName": "HBEGF positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "HBEGF positive indicates the presence of the HBEGF gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1839,
        "geneSymbol": "HBEGF",
        "terms": [
            "HBEGF",
            "DTR",
            "DTS",
            "DTSF",
            "HEGFL"
        ]
    },
    "variant": "positive",
    "createDate": "01/19/2018",
    "updateDate": "07/06/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12730,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, KHK2866 decreased serum Hbegf level in patients with advanced solid tumors, but also caused neuropsychiatric toxicity, which lead to the termination of the study (PMID: 26507836).",
            "molecularProfile": {
                "id": 28907,
                "profileName": "HBEGF positive"
            },
            "therapy": {
                "id": 6608,
                "therapyName": "KHK2866",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 10660,
                    "pubMedId": 26507836,
                    "title": "Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26507836"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28907,
            "profileName": "HBEGF positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}